The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Koreshkina M.I.

Tsentr golovnoĭ boli Mezhdunarodnoĭ kliniki MEDEM, Sankt-Peterburg

The use of noben (idebenone) in the complex treatment of episodic and chronic migraine

Authors:

Koreshkina M.I.

More about the authors

Read: 5508 times


To cite this article:

Koreshkina MI. The use of noben (idebenone) in the complex treatment of episodic and chronic migraine. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(6):98‑101. (In Russ.)

Recommended articles:
The rela­tionship of diet and nutrition with the frequency of migraine atta­cks. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):30-35
Biochemical features of migraine pathogenesis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):21-26
Complex treatment of a patient with seco­ndary headache following Chiari malformation type I and chro­nic tension-type headache. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(4):90-94
Changes in muscle tone after electrotherapy in patients suffering from chro­nic migraine and cervicalgia. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):96-101
Recu­rrent pain syndromes in adolescents of different ages. Russian Journal of Pain. 2025;(2):24-31
Prophylactic treatment of migraine in real clinical practice. Russian Journal of Pain. 2025;(2):63-69

References:

  1. Amelin A.V. Sovremennye aspekty diagnostiki, patogeneza i lecheniya migreni. M: OOO NTTs AMT 2007; 88.
  2. Bochkarev V.K., Faizulloev A.Z., Borodin V.I., Avedisova A.S. Psikhofiziologicheskaya kharakteristika deistviya nobena. Psikhiat i psikhofarmakol 2004; 06: 4.
  3. Voronkova K.V., Meleshkov M.N. Primenenie nobena (idobenon) v terapii pri dementsii i s narusheniyami pamyati, ne dostigshimi stepeni dementsii. Zhurn nevrol i psikhiat 2008; 4: 27-32.
  4. Damulin I.I. Primenenie idebenona (nobena) v nevrologicheskoi praktike. Zhurn nevrol i psikhiat 2006; 106: 11: 66-71.
  5. Naprienko M.V., Filatova E.G. Katadolon v lechenii khronicheskoi golovnoi boli napryazheniya. Lechenie nervnykh boleznei 2006; 1: 34-38.
  6. Osipova V.V., Voznesenskaya T.G. Komorbidnost' migreni: obzor literatury i podkhody k izucheniyu. Zhurn nevrol i psikhiat 2007; 107: 3: 64-73.
  7. Osipova V.V., Tabeeva G.R. Pervichnye golovnye boli. Prakticheskoe rukovodstvo. M 2007; 56.
  8. Osipova V.V. Golovnaya bol' napryazheniya. Prakticheskoe rukovodstvo dlya vrachei. M: OGTI. Reklamnaya prduktsiya 2008; 44.
  9. Rachin A.P. Farmakoekonomicheskoe obosnovanie primeneniya nazal'nogo spreya imigran. Atmosfera. Nervnye bolezni 2009; 2.
  10. Tabeeva G.R., Azimova Yu.E. Profilakticheskoe lechenie migreni. M 2009; 84.
  11. Fedin A.I., Rumyantseva S.A. Sovremennye podkhody k energokorrigiruyushchei terapii gipoksicheskikh porazhenii mozga. Consilium medicum: zhurnal dokazatel'noi meditsiny dlya praktikuyushchikh vrachei 2007; 9: 8: 104-105.
  12. Filatova E.G. READY - pervoe rossiiskoe mul'titsentrovoe issledovanie effektivnosti RELPAKSA (eletriptan) pri lechenii pristupov migreni. Lechenie zabolevanii nervnoi sistemy 2006; 2: 19: 38-43.
  13. Yakhno N.N., Parfenov V.A., Alekseev V.V. Golovnaya bol'. M: Remedium 2000; 150.
  14. BASH. Guidelines for all healthcare professional for the diagnosis and management of migraine, tension-type, cluster and medication-overuse headache. British Association for the Study of Headache 2007 www.bash.org.uk
  15. Geramel V., Darin N., Chretien D. Coenzyme Q10 and idebenone in the therapy of respiratory cchain diseases: rationale and comparative benefits. Mol Gent Metabol 2002; 77: 21-30.
  16. Headache classification subcommittee of the International Headache Society. The International Classification of Headache Disorders 2nd Edition. Cephalalgia 2004; 24: Suppl 1: 100-160.
  17. Igarashi H., Sakai F., Kan S. Magnetic resonance imaging of the brain in patients with migraine. Cephalalgia 1991; 11: 69-74.
  18. Leonardi M., Steiner T.J., Scher A.T., Lipton R.B. The Global Burden of migraine: measuring disability in headache disorders with WHO; Classification of Functioning Disability and health (ICF). J headache Pain 2005; 6: 429-440.
  19. Mordente A., Martorana G.E., Minotti G. Antioxidantties of 2,3 - dimethoxy -5-methyl - 6 -(10-hydroxydecyl) - 1,4- benzoquinone (idebenone). Chem Res Toxicol 1998; 11: 54-63.
  20. Olesen J., Bousser M.G., Diener H.C. Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006; 26: 742-746.
  21. Jensen R., Stovner L. Epidemiology and comorbidity of headache. Lancet Neurol 2008; 7: 4: 354-362.
  22. Sher A., Lipton R.B., Stewart W. Risk factor for chronic daily headache. Current Pain and Headache Reports 2002; 6: 486-491.
  23. Steiner T.J., Scher A.J., Stewart W.F. The prevalence and disability of adult migraine in England and their relationship to age, gender and ethnicity. Cephalalgia 2003; 23: 519-527.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.